Suppression of autophagy in osteocytes does not modify the adverse effects of glucocorticoids on cortical bone

Bone

Volumn 75, Issue , 2015, Pages 18-26

  Piemontese, Marilina ^a,c   Onal, Melda ^a,c   Xiong, Jinhu ^a,c   Wang, Yiying ^a,c   Almeida, Maria ^a,c   Thostenson, Jeff D ^b   Weinstein, Robert S ^a,c   Manolagas, Stavros C ^a,c   O'Brien, Charles A ^a,c  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^c CENTRAL ARKANSAS VETERANS HEALTHCARE SYSTEM   (United States)

Author keywords

Autophagy; Glucocorticoids; Osteocytes

Indexed keywords

CALCITONIN RECEPTOR; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; PREDNISOLONE; GLUCOCORTICOID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ATG GENE; AUTOPHAGY; BONE STRENGTH; BONE TURNOVER; CONTROLLED STUDY; CORTICAL BONE; CORTICAL THICKNESS (BONE); DMP1 CRE GENE; FEMALE; FEMUR; GENE; GENE DELETION; IMMUNOBLOTTING; LUMBAR VERTEBRA; MOUSE; NONHUMAN; OSTEOCYTE; POROSITY; PROTEIN DEGRADATION; ANIMAL; BONE; BONE DENSITY; BONE DEVELOPMENT; C57BL MOUSE; DRUG EFFECTS; METABOLISM; MICRO-COMPUTED TOMOGRAPHY; PATHOLOGY; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSGENIC MOUSE;

ANIMALS; AUTOPHAGY; BONE AND BONES; BONE DENSITY; GLUCOCORTICOIDS; IMMUNOBLOTTING; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; OSTEOCYTES; OSTEOGENESIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; X-RAY MICROTOMOGRAPHY;

EID: 84923169309     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2015.02.005     Document Type: Article

References (41)

1. Weinstein R.S. Clinical practice. Glucocorticoid-induced bone disease. N Engl J Med 2011, 365:62-70.
2. Weinstein R.S., Jilka R.L., Parfitt A.M., Manolagas S.C. Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone. J Clin Invest 1998, 102:274-282.
3. Rauch A., Seitz S., Baschant U., Schilling A.F., Illing A., Stride B., et al. Glucocorticoids suppress bone formation by attenuating osteoblast differentiation via the monomeric glucocorticoid receptor. Cell Metab 2010, 11:517-531.
4. O'Brien C.A., Jia D., Plotkin L.I., Bellido T., Powers C.C., Stewart S.A., et al. Glucocorticoids act directly on osteoblasts and osteocytes to induce their apoptosis and reduce bone formation and strength. Endocrinology 2004, 145:1835-1841.
5. Jia D., O'Brien C.A., Stewart S.A., Manolagas S.C., Weinstein R.S. Glucocorticoids act directly on osteoclasts to increase their life span and reduce bone density. Endocrinology 2006, 147:5592-5599.
6. Yang Z., Klionsky D.J. Eaten alive: a history of macroautophagy. Nat Cell Biol 2010, 12:814-822.
7. Mizushima N., Komatsu M. Autophagy: renovation of cells and tissues. Cell 2011, 147:728-741.
8. Levine B., Kroemer G. Autophagy in the pathogenesis of disease. Cell 2008, 132:27-42.
9. Komatsu M., Waguri S., Ueno T., Iwata J., Murata S., Tanida I., et al. Impairment of starvation-induced and constitutive autophagy in Atg7-deficient mice. J Cell Biol 2005, 169:425-434.
10. Jilka R.L. The relevance of mouse models for investigating age-related bone loss in humans. J Gerontol A Biol Sci Med Sci 2013, 68:1209-1217.
11. Ferguson V.L., Ayers R.A., Bateman T.A., Simske S.J. Bone development and age-related bone loss in male C57BL/6J mice. Bone 2003, 33:387-398.
12. Almeida M., Han L., Martin-Millan M., Plotkin L.I., Stewart S.A., Roberson P.K., et al. Skeletal involution by age-associated oxidative stress and its acceleration by loss of sex steroids. J Biol Chem 2007, 282:27285-27297.
13. Onal M., Piemontese M., Xiong J., Wang Y., Han L., Ye S., et al. Suppression of autophagy in osteocytes mimics skeletal aging. J Biol Chem 2013, 288:17432-17440.
14. Xia X., Kar R., Gluhak-Heinrich J., Yao W., Lane N.E., Bonewald L.F., et al. Glucocorticoid-induced autophagy in osteocytes. J Bone Miner Res 2010, 25:2479-2488.
15. Jia J., Yao W., Guan M., Dai W., Shahnazari M., Kar R., et al. Glucocorticoid dose determines osteocyte cell fate. FASEB J 2011, 25:3366-3376.
16. Lu Y., Xie Y., Zhang S., Dusevich V., Bonewald L.F., Feng J.Q. DMP1-targeted Cre expression in odontoblasts and osteocytes. J Dent Res 2007, 86:320-325.
17. Onal M., Xiong J., Cazer P., Manolagas S., O'Brien C. RANKL production by B lymphocytes contributes to the bone loss induced by inflammation and ovariectomy. J Bone Miner Res 2011, 26:S142.
18. Weinstein R.S., Wan C., Liu Q., Wang Y., Almeida M., O'Brien C.A., et al. Endogenous glucocorticoids decrease skeletal angiogenesis, vascularity, hydration, and strength in aged mice. Aging Cell 2010, 9:147-161.
19. Dempster D.W., Compston J.E., Drezner M.K., Glorieux F.H., Kanis J.A., Malluche H., et al. Standardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 2013, 28:2-17.
20. O'Brien C.A., Jilka R.L., Fu Q., Stewart S., Weinstein R.S., Manolagas S.C. IL-6 is not required for parathyroid hormone stimulation of RANKL expression, osteoclast formation, and bone loss in mice. Am J Physiol Endocrinol Metab 2005, 289:E784-E793.
21. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25:402-408.
22. Mizushima N., Yoshimori T., Levine B. Methods in mammalian autophagy research. Cell 2010, 140:313-326.
23. Bjorkoy G., Lamark T., Brech A., Outzen H., Perander M., Overvatn A., et al. p62/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on huntingtin-induced cell death. J Cell Biol 2005, 171:603-614.
24. Weinstein R.S., O'Brien C.A., Almeida M., Zhao H., Roberson P.K., Jilka R.L., et al. Osteoprotegerin prevents glucocorticoid-induced osteocyte apoptosis in mice. Endocrinology 2011, 152:3323-3331.
25. Xiong J., Onal M., Jilka R.L., Weinstein R.S., Manolagas S.C., O'Brien C.A. Matrix-embedded cells control osteoclast formation. Nat Med 2011, 17:1235-1241.
26. Kramer I., Halleux C., Keller H., Pegurri M., Gooi J.H., Weber P.B., et al. Osteocyte Wnt/beta-catenin signaling is required for normal bone homeostasis. Mol Cell Biol 2010, 30:3071-3085.
27. Komatsu M., Waguri S., Chiba T., Murata S., Iwata J., Tanida I., et al. Loss of autophagy in the central nervous system causes neurodegeneration in mice. Nature 2006, 441:880-884.
28. Warr M.R., Binnewies M., Flach J., Reynaud D., Garg T., Malhotra R., et al. FOXO3A directs a protective autophagy program in haematopoietic stem cells. Nature 2013, 494:323-327.
29. Jung H.S., Chung K.W., Won K.J., Kim J., Komatsu M., Tanaka K., et al. Loss of autophagy diminishes pancreatic beta cell mass and function with resultant hyperglycemia. Cell Metab 2008, 8:318-324.
30. Jiang M., Wei Q., Dong G., Komatsu M., Su Y., Dong Z. Autophagy in proximal tubules protects against acute kidney injury. Kidney Int 2012, 82:1271-1283.
31. Almeida M., Han L., Ambrogini E., Weinstein R.S., Manolagas S.C. Glucocorticoids and tumor necrosis factor alpha increase oxidative stress and suppress Wnt protein signaling in osteoblasts. J Biol Chem 2011, 286:44326-44335.
32. Kroemer G., Marino G., Levine B. Autophagy and the integrated stress response. Mol Cell 2010, 40:280-293.
33. Mullender M.G., van der Meer D.D., Huiskes R., Lips P. Osteocyte density changes in aging and osteoporosis. Bone 1996, 18:109-113.
34. Jain M.V., Paczulla A.M., Klonisch T., Dimgba F.N., Rao S.B., Roberg K., et al. Interconnections between apoptotic, autophagic and necrotic pathways: implications for cancer therapy development. J Cell Mol Med 2013, 17:12-29.
35. Eisenberg-Lerner A., Bialik S., Simon H.U., Kimchi A. Life and death partners: apoptosis, autophagy and the cross-talk between them. Cell Death Differ 2009, 16:966-975.
36. Laane E., Tamm K.P., Buentke E., Ito K., Kharaziha P., Oscarsson J., et al. Cell death induced by dexamethasone in lymphoid leukemia is mediated through initiation of autophagy. Cell Death Differ 2009, 16:1018-1029.
37. Weinstein R.S. Glucocorticoids, osteocytes, and skeletal fragility: the role of bone vascularity. Bone 2010, 46:564-570.
38. Guanabens N., Gifre L., Peris P. The role of Wnt signaling and sclerostin in the pathogenesis of glucocorticoid-induced osteoporosis. Curr Osteoporos Rep 2014, 12:90-97.
39. Kim H.J., Zhao H., Kitaura H., Bhattacharyya S., Brewer J.A., Muglia L.J., et al. Glucocorticoids suppress bone formation via the osteoclast. J Clin Invest 2006, 116:2152-2160.
40. Weinstein R.S., Chen J.R., Powers C.C., Stewart S.A., Landes R.D., Bellido T., et al. Promotion of osteoclast survival and antagonism of bisphosphonate-induced osteoclast apoptosis by glucocorticoids. J Clin Invest 2002, 109:1041-1048.
41. Thiele S., Ziegler N., Tsourdi E., De B.K., Tuckermann J.P., Hofbauer L.C., et al. Selective glucocorticoid receptor modulation maintains bone mineral density in mice. J Bone Miner Res 2012, 27:2242-2250.